ABVC vs AMT · rev $796.0K vs P/E 31, rev $10.64B
ABVC Biopharma Inc (ABVC) versus American Tower Corp (AMT) — a side-by-side from cached financials, not a winner call.
ABVC Biopharma Inc (ABVC) is a biotechnology company listed on NASDAQ.
American Tower Corp (AMT) is a reit - specialty company listed on US.
Latest reported ABVC revenue for 2025-09-30 was $796.0K. Net income was -$1.3M. ABVC currently screens at market cap $35.9M.
Latest reported AMT revenue for 2025-12-31 was $10.64B. Net income was $2.63B. Revenue was up 317.8% from 2024-12-31 to 2025-12-31. AMT currently screens at market cap $90.44B and trailing P/E 31.4.
ABVC currently screens at market cap $35.9M. AMT currently screens at market cap $90.44B and trailing P/E 31.4.
Not investment advice. Open the ABVC and AMT stock pages for the full models.
Not investment advice.